| EX1542 MYASTHENIA GRAVIS PANEL |
| Specimen: |
5 mL (3 mL min.) serum from 2 SSTs. Ship refrigerated or frozen. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 2 hrs |
1 week |
2 weeks |
|
| Method: |
Radioimmunoassay, IFA |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Myasthenia gravis (MG) is a neuromuscular junction disorder characterized by muscle weakness & easy fatigability most commonly due to autoantibody mediated loss of functional acetylcholine receptors in the postsynaptic membrane of skeletal muscle. MG has a prevalence of 200 in 100,000 affecting all age groups but the peak incidence is in women in the 20 to 30 years age group. Men are less frequently affected and are usually in the 50 to 60 years age group. The course of MG is variable with remissions & exacerbations, especially during the first few years after the onset of the disease. Ptosis & diplopia are common symptoms. |
| Doctor Specialty: |
Neurologist |
| Disease: |
Myasthenia gravis |
| Components: |
*Acetylcholine Receptor Binding Antibody *Striated / Skeletal Muscle Antibody in Dilutions *MuSK Antibody |
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
IMMUNOASSAY |
| Pre Test Information: |
The patient should not have general anesthetic or muscle relaxant drugs 24 prior to sampling. |
Reviews
There are no reviews yet.